At present, there had been many reports detailing the role of AQP9 in liver cancer, renal cell carcinoma, and NAFLD, but no reports had been found on the pathogenesis of AQP9 in the comorbidity of IBD and psoriasis. This evidence concerns the gene AQP9 and metabolic dysfunction-associated steatotic liver disease.